A375R cells were generated by continuous selective culture in vemurafenib; immunoblot-detection verified PDGFR-upregulation in these cells, a recognised signature molecular modification quality of vemurafenib-resistant melanoma cells (Body 6B) [19]. iodide movement cytometry, and PMS-induced cell loss of life was suppressed by antioxidant (NAC) or pan-caspase inhibitor (zVAD-fmk) cotreatment. Gene appearance array evaluation in A375 melanoma […]